Skip to main content
ONC logo

ONC · BeOne Medicines Ltd. · Executive Compensation

Track ONC — free
$416.54 +0.58 (+0.14%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Market Cap
$47.58B
Shares
114.23M
Volume · Nov 13 345.46K Avg daily vol (3M) 404.68K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Margaret Dugan Appointed 2026-06-11
John V. Oyler Appointed 2026-06-11
Elizabeth F. Mooney Appointed 2026-06-11
Charles L. Sawyers Appointed 2026-06-11
Felix J. Baker Appointed 2026-06-11
Dr. Lai Wang Appointed 2025-12-18
Shalini Sharp Appointed 2024-09-26
Julia Wang Resigned 2024-07-18
Aaron Rosenberg Appointed 2024-07-18
Titus Ball Appointed 2024-03-20
Olivier Brandicourt Appointed 2024-01-23
Thomas Malley Resigned 2024-01-23

Leadership

Key facts CIK 1651308 CUSIP 07725L102 13F (30d) 269 filings 245 filers Visit website Investor relations